• No results found

Methodological quality of included studies (ordered by study ID) . 117

2 Materials and Methods

3.2 Risk of bias in included studies

3.2.1 Methodological quality of included studies (ordered by study ID) . 117

by study ID)

AASK 2002

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Low risk The randomisation was stratified by city using randomly permuted blocks

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment Incomplete outcome data

(attrition bias) Low risk Patients withdrawing from the study were accounted. ITT analysis was performed Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Unclear risk

A number of BP-lowering agents were added to randomly allocated treatment to control BP. The observed effects could equally have resulted from the different additional drugs

ACCOMPLISH 2004

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Low risk Randomization scheme was generated by computer

Allocation concealment

(selection bias) Low risk Central randomisation Blinding of participants

and personnel (performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment Incomplete outcome data

(attrition bias) Unclear risk It is unclear whether an ITT or PP analysis was used

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Unclear risk

A number of BP-lowering agents were added to randomly allocated treatment to control BP. The observed effects could equally have resulted from the different additional drugs

Alcocer 1995

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Low risk The randomisation was stratified by centres using randomly permuted blocks

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded

Blinding of outcome assessment (detection bias)

Low risk Blind outcome assessment Incomplete outcome data

(attrition bias) Low risk Patients withdrawing from the study were accounted. ITT analysis was performed Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

ALLHAT 2002

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias)

Low risk Randomization scheme was generated by computer

Allocation concealment

(selection bias) Low risk Concealment scheme was implemented at the clinical trials centre and stratified by centre Blinding of participants

and personnel (performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment

Incomplete outcome data

(attrition bias) Low risk

Two centres initially reported were excluded, due poor documentation of informed consent. ITT analysis was performed

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Unclear risk

A number of BP-lowering agents were added to randomly allocated treatment to control BP. The observed effects could equally have resulted from the different additional drugs

ALPINE 2003

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment

Incomplete outcome data

(attrition bias) Low risk

Not indicated whether reasons for missing outcome data were similar across treatment groups. Modified ITT analysis was performed including all randomised patients who had completed the study and had taken at least one dose of study drug

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

ASCOT-BPLA 2005

Bias Authors'

judgement Support for judgement

Random sequence generation (selection bias)

Low risk Randomization scheme was generated by computer

Allocation concealment

(selection bias) Low risk Central randomisation Blinding of participants

and personnel (performance bias)

High risk Study drugs were administered open-label Blinding of outcome

assessment (detection bias)

Low risk A PROBE design was used.

Incomplete outcome data

(attrition bias) Low risk

Two centres with 85 patients initially reported were excluded, due data integrity concerns. ITT analysis was performed

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

Benetos 2000

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment

Incomplete outcome data

(attrition bias) Low risk

Not indicated whether reasons for missing outcome data were similar across treatment groups. Modified ITT analysis was performed including all randomly assigned patients who received at least one dose of the study

medication, had one baseline BP measurement, and at least one subsequent BP measurement Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

Black 1997

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias)

Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment

Incomplete outcome data

(attrition bias) Low risk

Not indicated whether reasons for missing outcome data were similar across treatment groups. Modified ITT analysis was performed including all randomised patients with a baseline

measurement and at least one post treatment observation

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported.

Other bias Low risk No other possible bias was found.

Black 2001

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment Incomplete outcome data

(attrition bias) Unclear risk It is unclear whether an ITT or PP analysis was used

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

Bremner 1997

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Unclear risk It is unclear whether blinding was broken prior to making final decision to withdraw

Incomplete outcome data

(attrition bias) Low risk Patients withdrawing from the study were accounted. ITT analysis was performed Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

CASE-J 2008

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Low risk Randomization scheme was generated by computer

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

High risk Participants and personnel were not blinded Blinding of outcome

assessment (detection bias)

Low risk A PROBE design was used.

Incomplete outcome data

(attrition bias) Low risk Patients withdrawing from the study were accounted. ITT analysis was performed

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

Chanudet 2001

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment Incomplete outcome data

(attrition bias) High risk Data of withdrawn patients were not included. PP analyses was used

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

CONVINCE 2003

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Low risk IVRS, for randomising, assigning, and tracking blinded medication was used

Allocation concealment

(selection bias) Low risk IVRS, for randomising, assigning, and tracking blinded medication was used

Blinding of participants and personnel

(performance bias)

High risk A number of patients discontinued blinded medication (administered open-label) Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment

Incomplete outcome data

(attrition bias) Low risk

Participants from two centres with 126 patients were excluded, due to data integrity concerns.

ITT analysis was performed Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Unclear risk

A number of BP-lowering agents were added to randomly allocated treatment to control BP. The observed effects could equally have resulted from the different additional drugs

Cremonesi 2002

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

High risk Participants and personnel were not blinded Blinding of outcome

assessment (detection bias)

High risk Study drugs were administered open-label

Incomplete outcome data

(attrition bias) Low risk Patients withdrawing from the study were accounted. ITT analysis was performed Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

CROSS 2003

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment

Incomplete outcome data

(attrition bias) Low risk

Not indicated whether reasons for missing outcome data were similar across treatment groups. Modified ITT analysis was performed including all patients allocated randomly to groups, provided that they had received at least one dose of the study medication and had post- baseline data

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported.

Other bias Low risk No other possible bias was found

Cushman 1998

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment Incomplete outcome data

(attrition bias) Low risk Patients withdrawing from the study were accounted. ITT analysis was performed Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

Derosa 2013

Low risk Randomization scheme was generated by computer

Allocation concealment (selection bias)

Low risk Central randomisation Blinding of participants

and personnel (performance bias)

Low risk

Participants and personnel blinded

Blinding of outcome

Low risk Not indicated whether reasons for missing outcome data were similar across treatment groups. Modified ITT analysis was performed including patients who had received at least one dose of study medication and had a subsequent efficacy observation

Selective reporting (reporting bias)

Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

Derosa 2014

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Low risk Randomization scheme was generated by computer

Allocation concealment

(selection bias) Low risk

Allocation concealment was done with envelopes containing randomisation codes prepared by statisticians

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment Incomplete outcome data

(attrition bias) Unclear risk It is unclear whether an ITT or PP analysis was used

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

DETAIL 2004

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Unclear risk It is unclear whether blinding was broken prior to making final decision to withdraw

Incomplete outcome data

(attrition bias) Low risk Patients withdrawing from the study were accounted. ITT analysis was performed Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

ELLE 2003

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment Incomplete outcome data

(attrition bias) High risk Data of withdrawn patients were not included.

PP analyses was used Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

ELSA 2002

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Low risk Randomization scheme was generated by computer

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment

Incomplete outcome data

(attrition bias) Low risk

Not mentioned whether reasons for missing outcome data were similar between treatment groups. Modified ITT analysis was performed including all patients randomised to double blind medication who had the baseline ultrasound scan and at least one follow-up scan, including scans performed after withdrawal

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

ELVERA 2004

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment

Incomplete outcome data

(attrition bias) Low risk

Not indicated whether reasons for missing outcome data were similar across treatment groups. Modified ITT analysis was performed including patients for whom there were valid readings at baseline and at least one valid observation after 1 and 2 years

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

FACET 1998

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Low risk Randomization scheme was generated by computer

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

High risk Study drugs were administered open-label Blinding of outcome

assessment (detection bias)

High risk Outcome assessment not blinded Incomplete outcome data

(attrition bias) Low risk Patients withdrawing from the study were accounted. ITT analysis was performed Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Unclear risk

A number of BP-lowering agents were added to randomly allocated treatment to control BP. The observed effects could equally have resulted from the different additional drugs

Farsang 2007

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment Incomplete outcome data

(attrition bias) Low risk Patients withdrawing from the study were accounted. ITT analysis was performed Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

Fogari 2008

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Low risk Randomization scheme was generated by computer

Allocation concealment

(selection bias) Low risk Central randomisation Blinding of participants

and personnel (performance bias)

High risk Study drugs were administered open-label Blinding of outcome

assessment (detection bias)

Low risk A PROBE design was used.

Incomplete outcome data

(attrition bias) Unclear risk It is unclear whether an ITT or PP analysis was used

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

Freytag 2001

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described.

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described.

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded.

Blinding of outcome assessment (detection bias)

Low risk Blind outcome assessment.

Incomplete outcome data

(attrition bias) Low risk Patients withdrawing from the study were accounted. ITT analysis was performed.

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported.

Other bias Low risk No other possible bias was found.

Giles 2007

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment

Incomplete outcome data

(attrition bias) Low risk

Not indicated whether reasons for missing outcome data were similar across treatment groups. Modified ITT analysis was performed including patients who received at least 1 dose of study drug and had a baseline BP

measurement and at least one post baseline BP assessment

Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

Grassi 2003

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment Incomplete outcome data

(attrition bias) High risk Data of withdrawn patients were not included.

PP analyses was used Selective reporting

(reporting bias) Low risk Outcomes listed in the methods section were all reported

Other bias Low risk No other possible bias was found

Greathouse 2010

Bias Authors'

judgement Support for judgement Random sequence

generation (selection bias) Unclear risk Method of sequence generation was not described

Allocation concealment

(selection bias) Unclear risk Method of allocation concealment was not described

Blinding of participants and personnel

(performance bias)

Low risk Participants and personnel blinded Blinding of outcome

assessment (detection bias)

Low risk Blind outcome assessment

Incomplete outcome data

(attrition bias) Low risk

Not indicated whether reasons for missing outcome data were similar across treatment groups. Modified ITT analysis was performed including all randomised patients who received at least one dose of study medication.

Not indicated whether reasons for missing outcome data were similar across treatment groups. Modified ITT analysis was performed including all randomised patients who received at least one dose of study medication.